| Breast cancer in China L Fan, K Strasser-Weippl, JJ Li, J St Louis, DM Finkelstein, KD Yu, ... The lancet oncology 15 (7), e279-e289, 2014 | 1729 | 2014 |
| Extending aromatase-inhibitor adjuvant therapy to 10 years PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, ... New England Journal of Medicine 375 (3), 209-219, 2016 | 713 | 2016 |
| Planning cancer control in Latin America and the Caribbean PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ... The lancet oncology 14 (5), 391-436, 2013 | 633 | 2013 |
| Challenges to effective cancer control in China, India, and Russia PE Goss, K Strasser-Weippl, BL Lee-Bychkovsky, L Fan, J Li, ... The lancet oncology 15 (5), 489-538, 2014 | 561 | 2014 |
| Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer LU Thompson, JM Chen, T Li, K Strasser-Weippl, PE Goss Clinical cancer research 11 (10), 3828-3835, 2005 | 416 | 2005 |
| Aromatase inhibitors in the treatment and prevention of breast cancer PE Goss, K Strasser Journal of Clinical Oncology 19 (3), 881-894, 2001 | 408 | 2001 |
| Symptomatology of anemia H Ludwig, K Strasser Seminars in oncology 28, 7-14, 2001 | 355 | 2001 |
| Progress and remaining challenges for cancer control in Latin America and the Caribbean K Strasser-Weippl, Y Chavarri-Guerra, C Villarreal-Garza, BL Bychkovsky, ... The lancet oncology 16 (14), 1405-1438, 2015 | 202 | 2015 |
| Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ... Annals of oncology 33 (12), 1250-1268, 2022 | 185 | 2022 |
| Current status and future projections of breast cancer in Asia L Fan, PE Goss, K Strasser-Weippl Breast care 10 (6), 372-378, 2015 | 132 | 2015 |
| Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review R Ruiz, C Herrero, K Strasser-Weippl, D Touya, JS Louis, A Bukowski, ... The Breast 35, 136-141, 2017 | 106 | 2017 |
| Advances in adjuvant hormonal therapy for postmenopausal women K Strasser-Weippl, PE Goss Journal of Clinical Oncology 23 (8), 1751-1759, 2005 | 95 | 2005 |
| Aromatase inhibitors for chemoprevention PE Goss, K Strasser-Weippl Best Practice & Research Clinical Endocrinology & Metabolism 18 (1), 113-130, 2004 | 82 | 2004 |
| Prevention strategies with aromatase inhibitors PE Goss, K Strasser-Weippl Clinical Cancer Research 10 (1), 372s-379s, 2004 | 73 | 2004 |
| Improving access to high‐cost cancer drugs in Latin America: Much to be done R Ruiz, K Strasser‐Weippl, D Touya, C Herrero Vincent, ... Cancer 123 (8), 1313-1323, 2017 | 66 | 2017 |
| Cervical cancer control in Latin America: A call to action BL Bychkovsky, ME Ferreyra, K Strasser‐Weippl, CI Herold, ... Cancer 122 (4), 502-514, 2016 | 65 | 2016 |
| Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma K Strasser‐Weippl, H Ludwig European journal of haematology 81 (5), 374-379, 2008 | 61 | 2008 |
| Prolactin and breast cancer: the need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: a review D Froes Brandao, K Strasser‐Weippl, PE Goss Cancer 122 (2), 184-188, 2016 | 48 | 2016 |
| Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma D Heintel, N Zojer, M Schreder, K Strasser-Weippl, B Kainz, M Vesely, ... Leukemia 22 (2), 441-445, 2008 | 47 | 2008 |
| Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors PE Goss, K Strasser Drugs 62, 957-966, 2002 | 43 | 2002 |
